Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Chickenpox × fludarabine phosphate × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Leukemia, Myeloid, Acute 203 Leukemia, Lymphocytic, Chronic, B-Cell 190 Leukemia 178 Myelodysplastic Syndromes 163 Precursor Cell Lymphoblastic Leukemia-Lymphoma 150 Lymphoma 130 Lymphoma, Non-Hodgkin 124 Multiple Myeloma 109 Hodgkin Disease 107 Lymphoma, Follicular 97 Lymphoma, Mantle-Cell 94 Lymphoma, Large B-Cell, Diffuse 82 Lymphoma, B-Cell, Marginal Zone 77 Myeloproliferative Disorders 76 Burkitt Lymphoma 75 Congenital Abnormalities 70 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 69 Leukemia, Myelomonocytic, Chronic 67 Leukemia, Myeloid, Accelerated Phase 64 Leukemia, Myeloid, Chronic-Phase 63 Melanoma 56 Lymphoma, Large-Cell, Immunoblastic 53 Recurrence 52 Anemia, Refractory, with Excess of Blasts 51 Primary Myelofibrosis 49 Blast Crisis 48 Neoplasms, Plasma Cell 46 Waldenstrom Macroglobulinemia 45 Hematologic Neoplasms 43 Dendritic Cell Sarcoma, Interdigitating 38

Interventions

fludarabine phosphate 1 fludarabine 1 Herpes Zoster Vaccine 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01953900 2026-01-23

VEGAS

Baylor College of Medicine

Phase 1 Active not recruiting

Chickenpox, Neuroblastoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡